ID: ALA6603

Max Phase: Preclinical

Molecular Formula: C18H22N2

Molecular Weight: 266.39

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCNCC1NCC(c2ccccc2)c2ccccc21

Standard InChI:  InChI=1S/C18H22N2/c1-2-19-13-18-16-11-7-6-10-15(16)17(12-20-18)14-8-4-3-5-9-14/h3-11,17-20H,2,12-13H2,1H3

Standard InChI Key:  HSNLDJSGPCJLBB-UHFFFAOYSA-N

Associated Targets(non-human)

Muscarinic acetylcholine receptor M5 132 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 266.39Molecular Weight (Monoisotopic): 266.1783AlogP: 3.07#Rotatable Bonds: 4
Polar Surface Area: 24.06Molecular Species: BASEHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.32CX LogP: 3.12CX LogD: 1.20
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.89Np Likeness Score: 0.36

References

1. Griffith RC, Gentile RJ, Robichaud RC, Frankenheim J..  (1984)  cis-1,3,4,6,7,11b-Hexahydro-2-methyl-7-phenyl-2H-pyrazino[2,1-a] isoquinoline: a new atypical antidepressant.,  27  (8): [PMID:6747997] [10.1021/jm00374a011]

Source